The study includes participants experiencing distress with regard to stopping immunotherapy and will utilize cognitive-behavioral therapy to reduce fear of recurrence, depression, and anxiety and improve quality of life.
Cognitive Behavioral Therapy
The study includes participants experiencing distress with regard to stopping immunotherapy and will utilize cognitive-behavioral therapy to reduce fear of recurrence, depression, and anxiety and improve quality of life.
Fear of Recurrence and Stopping Immunotherapy
-
UPMC Hillman Cancer Centers, Pittsburgh, Pennsylvania, United States, 15213
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
21 Years to
ALL
No
University of Pittsburgh,
Jason Luke, PRINCIPAL_INVESTIGATOR, Hillman Cancer Center
2026-08-31